Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07793006 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease

Name: New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease — clinical trial record (NCT07793006)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot applicable

SponsorIndiana University

Started2025-03-17

View on ClinicalTrials.gov ↗

Persons living with HIV (PLWH) in sub-Saharan Africa (SSA), lymphadenopathy often portends one of a number of life-threatening diseases including tuberculosis, lymphoma, and multicentric Castleman disease (MCD). Overcoming these delays and missed diagnoses requires new approaches to identify lymphoma and MCD.

Trial Details

NCT Number	NCT07793006
Lead Sponsor	Indiana University Collaborators: UNC Lineberger Comprehensive Cancer Center, National Institutes of Health (NIH)
Conditions	HIV, Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Tiny Isothermal Nucleic Acid Amplification System, Lymphadenopathy
Enrollment	500 participants
Start Date	2025-03-17
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-28